Daniel Poor

NPI: 1316352099
Total Payments
$3,101
2024 Payments
$31.20
Companies
11
Transactions
37
Medicare Patients
3,115
Medicare Billing
$424,430

Payment Breakdown by Category

Other$2,575 (83.0%)
Food & Beverage$525.57 (17.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,575 5 83.0%
Food and Beverage $525.57 32 17.0%

Top Paying Companies

Company Total Records Latest Year
Alexion Pharmaceuticals, Inc. $1,459 5 $0 (2022)
AstraZeneca Pharmaceuticals LP $1,212 4 $0 (2022)
Janssen Pharmaceuticals, Inc $160.87 12 $0 (2021)
CSL Behring $68.58 3 $0 (2021)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $48.88 3 $0 (2021)
PFIZER INC. $44.29 3 $0 (2019)
E.R. Squibb & Sons, L.L.C. $42.62 3 $0 (2021)
Biosense Webster, Inc. $17.43 1 $0 (2024)
BOSTON SCIENTIFIC CORPORATION $16.87 1 $0 (2021)
Mallinckrodt LLC $15.97 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $31.20 2 Biosense Webster, Inc. ($17.43)
2022 $1,797 5 AstraZeneca Pharmaceuticals LP ($1,200)
2021 $978.67 10 Alexion Pharmaceuticals, Inc. ($861.48)
2020 $77.65 6 Janssen Pharmaceuticals, Inc ($49.24)
2019 $199.67 13 Janssen Pharmaceuticals, Inc ($81.68)
2018 $15.97 1 Mallinckrodt LLC ($15.97)

All Payment Transactions

37 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/17/2024 Biosense Webster, Inc. CARTO 3 (Device) Food and Beverage In-kind items and services $17.43 General
Category: Cardiology
10/07/2024 Octapharma USA, Inc. BALFAXAR (Biological) Food and Beverage In-kind items and services $13.77 General
Category: INTENSIVE CAREEMERGENCY
05/10/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $450.00 General
Category: Rare Disease
03/24/2022 Alexion Pharmaceuticals, Inc. ANDEXXA (Biological) Food and Beverage In-kind items and services $47.41 General
Category: Rare Disease
02/20/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $450.00 General
Category: Rare Disease
02/20/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $300.00 General
Category: Rare Disease
01/04/2022 Alexion Pharmaceuticals, Inc. ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $550.00 General
Category: Rare Disease
10/14/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $15.22 General
Category: Cardiovascular & Metabolism
10/06/2021 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $17.10 General
Category: Cardiovascular
09/15/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Food and Beverage In-kind items and services $18.12 General
Category: Hematology
09/09/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $14.73 General
Category: Cardiovascular & Metabolism
08/18/2021 BOSTON SCIENTIFIC CORPORATION EKOSONIC (Device) Food and Beverage In-kind items and services $16.87 General
Category: THROMBECTOMY
05/20/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $12.85 General
Category: Gastroenterology
05/11/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $825.00 General
Category: Hematology
05/06/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Food and Beverage In-kind items and services $18.36 General
Category: Hematology
02/24/2021 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $11.77 General
Category: Cardiovascular
01/12/2021 CSL Behring Kcentra (Biological) Food and Beverage In-kind items and services $28.65 General
Category: Trauma (Emergency, Injury, Surgery)
08/11/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $11.29 General
Category: Cardiovascular & Metabolism
06/25/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $12.54 General
Category: Cardiovascular & Metabolism
04/15/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $11.98 General
Category: Cardiovascular & Metabolism
04/04/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $12.40 General
Category: Cardiovascular and Metabolism
03/04/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $13.43 General
Category: Cardiovascular & Metabolism
02/19/2020 CSL Behring Kcentra (Biological) Food and Beverage In-kind items and services $16.01 General
Category: Trauma (Emergency, Injury, Surgery)
11/12/2019 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $13.75 General
Category: Cardiovascular
10/08/2019 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug), XIFAXAN Food and Beverage In-kind items and services $17.68 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 666 690 $1.1M $82,004
2022 5 760 800 $1.3M $106,562
2021 6 779 794 $1.1M $111,006
2020 5 910 939 $1.2M $124,859
Total Patients
3,115
Total Services
3,223
Medicare Billing
$424,430
Procedure Codes
21

All Medicare Procedures & Services

21 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 440 456 $777,912 $60,105 7.7%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 174 177 $206,342 $15,700 7.6%
99291 Critical care, first 30-74 minutes Facility 2023 25 26 $53,664 $3,972 7.4%
31500 Emergent insertion of breathing tube into windpipe using an endoscope Facility 2023 11 11 $12,903 $1,150 8.9%
99283 Emergency department visit with low level of medical decision making Facility 2023 16 20 $14,960 $1,077 7.2%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 505 536 $915,024 $75,776 8.3%
99291 Critical care, first 30-74 minutes Facility 2022 94 95 $191,418 $16,124 8.4%
99284 Emergency department visit for problem of high severity Facility 2022 113 119 $137,115 $11,002 8.0%
99283 Emergency department visit for problem of moderate severity Facility 2022 31 33 $24,654 $1,847 7.5%
31500 Emergent insertion of breathing tube into windpipe using an endoscope Facility 2022 17 17 $19,431 $1,812 9.3%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 526 540 $762,717 $78,327 10.3%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 119 119 $209,261 $21,206 10.1%
99284 Emergency department visit, problem of high severity Facility 2021 72 73 $78,132 $7,163 9.2%
31500 Emergent insertion of breathing tube into windpipe cartilage using an endoscope Facility 2021 19 19 $21,861 $2,058 9.4%
99283 Emergency department visit, moderately severe problem Facility 2021 32 32 $21,790 $1,762 8.1%
36680 Insertion of needle for infusion into bone Facility 2021 11 11 $5,259 $489.94 9.3%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 648 669 $863,971 $90,262 10.4%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 134 136 $223,186 $23,615 10.6%
99284 Emergency department visit, problem of high severity Facility 2020 77 78 $77,284 $7,178 9.3%
99283 Emergency department visit, moderately severe problem Facility 2020 35 40 $24,902 $2,030 8.2%
31500 Emergent insertion of breathing tube into windpipe cartilage using an endoscope Facility 2020 16 16 $17,595 $1,775 10.1%

About Daniel Poor

Daniel Poor is a Emergency Medicine healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2014. The National Provider Identifier (NPI) number assigned to this provider is 1316352099.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Poor has received a total of $3,101 in payments from pharmaceutical and medical device companies, with $31.20 received in 2024. These payments were reported across 37 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2,575).

As a Medicare-enrolled provider, Poor has provided services to 3,115 Medicare beneficiaries, totaling 3,223 services with total Medicare billing of $424,430. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Other Specialties Emergency Medicine, Student in an Organized Health Care Education/Training Program
  • Location Memphis, TN
  • Active Since 06/21/2014
  • Last Updated 07/17/2018
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1316352099

Products in Payments

  • ANDEXXA (Biological) $1,797
  • Andexxa (Drug) $861.48
  • XARELTO (Drug) $160.87
  • ELIQUIS (Drug) $86.91
  • Kcentra (Biological) $68.58
  • RELISTOR (Drug) $36.03
  • CARTO 3 (Device) $17.43
  • EKOSONIC (Device) $16.87
  • OFIRMEV (Drug) $15.97
  • BALFAXAR (Biological) $13.77
  • XIFAXAN (Drug) $12.85
  • LOKELMA (Drug) $12.40

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Memphis